Efficacy-effectiveness gap with immune checkpoint inhibitors in solid cancers: A population based cohort study

被引：0
|
作者：
Niraula, Saroj [1 ]
机构：
[1] Univ Manitoba, CancerCare Manitoba, Winnipeg, MB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6625
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Hyperprogression in various solid cancers treated with immune checkpoint inhibitors in the real world.
    Kim, Jwa Hoon
    Lee, Soohyeon
    Hong, Min Hee
    Kim, Jee Hyun
    Kang, Eun Joo
    Kim, Tae-Yong
    Park, Yeon Hee
    Han, Ji-Youn
    Kim, Il-Hwan
    Kim, Sang-We
    Lee, Dae Ho
    Lee, Jae Lyun
    Lee, Jae Cheol
    Choi, Chang-Min
    Yoo, Changhoon
    Yoon, Shinkyo
    Jeong, Jae Ho
    Seo, Seyoung
    Kim, Sun Young
    Ahn, Jin-Hee
    Park, Sook Ryun
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
    Gong, Xiaoling
    Zhu, Yahui
    Zhang, Qianning
    Qiu, Xin
    Lu, Changchang
    Tong, Fan
    Wang, Qiaoli
    Kong, Weiwei
    Zhou, Haihui
    Liu, Baorui
    Zhou, Yujie
    Du, Juan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [23] The impact of antibiotics on efficacy of immune checkpoint inhibitors in malignancies: A study based on 44 cohorts
    Wu, Qing
    Liu, Junjin
    Wu, Sumei
    Xie, Xianhe
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
  • [24] The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours
    Haik, Laura
    Gonthier, Aurore
    Quivy, Amandine
    Gross-goupil, Marine
    Veillon, Remi
    Frison, Eric
    Ravaud, Alain
    Domblides, Charlotte
    Daste, Amaury
    ACTA ONCOLOGICA, 2021, 60 (12) : 1597 - 1603
  • [25] Longitudinal observational studies to study the efficacy-effectiveness gap in drug therapy: Application to mild and moderate dementia
    MacDonald, KM
    Vancayzeele, S
    Deblander, A
    Abraham, IL
    NURSING CLINICS OF NORTH AMERICA, 2006, 41 (01) : 105 - +
  • [26] Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population
    Xiaoyuan Yu
    Li Zhao
    Bin Song
    BMC Pulmonary Medicine, 22
  • [27] Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population
    Yu, Xiaoyuan
    Zhao, Li
    Song, Bin
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [28] Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study
    Bjornhart, Birgitte
    Hansen, Karin H.
    Jorgensen, Trine L.
    Herrstedt, Jorn
    Schytte, Tine
    ACTA ONCOLOGICA, 2019, 58 (07) : 953 - 961
  • [29] Clinically significant bleeding with immune checkpoint inhibitors: A retrospective cohort study
    Kewan, Tariq
    Covut, Fahrettin
    Ahmed, Ramsha
    Haddad, Abdo
    Daw, Hamed
    EUROPEAN JOURNAL OF CANCER, 2020, 137 : 285 - 287
  • [30] Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study
    Tan, S.
    Spear, E.
    Sane, N.
    Chan, J.
    Nelson, A. J.
    Nerlekar, N.
    Segelov, E.
    Nicholls, S. J.
    EUROPEAN HEART JOURNAL, 2023, 44
12345